Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
about
Small molecule inhibitors of the HIV-1 virulence factor, NefStructural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibodyIdentification of a candidate therapeutic autophagy-inducing peptideA hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2.Hydrogen Exchange Mass Spectrometry of Related Proteins with Divergent Sequences: A Comparative Study of HIV-1 Nef Allelic Variants.In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix.Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity.Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization.Self-association of the Lentivirus protein, NefTrans-cellular introduction of HIV-1 protein Nef induces pathogenic response in Caenorhabditis elegans.Structural constraints on human immunodeficiency virus type 1 Nef function.Nef-specific CD8+ T cell responses contribute to HIV-1 immune control.Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 NefProteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variantsMaintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists.CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variableNef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.Association with PAK2 Enables Functional Interactions of Lentiviral Nef Proteins with the Exocyst Complex.Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor.Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I.A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2Functional characterization of the human immunodeficiency virus type 1 Nef acidic domain.HIV-1 Nef: at the crossroadsA basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex.Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication.Mechanisms of HIV-1 Nef function and intracellular signaling.Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanisms.The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.Proteomics in the investigation of HIV-1 interactions with host proteins.Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.Modulation of HIV pathogenesis and T-cell signaling by HIV-1 NefHIV-1 Nef: hacker of the host cell.Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue.
P2860
Q27013915-82B30D58-83C7-4B6F-94E1-D56DC426184BQ27682132-66A513AF-6E99-49A7-AD1C-45E0CC9B0D71Q28593490-4352E4A8-6143-43E0-9D91-C4BAC73635C5Q28768294-95ACBC4B-1682-4867-9868-FDCC6D2EBB3BQ30008993-9F8C1ABC-EE0A-40C8-9A7F-947E65447618Q30009533-2B61EB33-7C07-4565-9C8E-416A5C37BE62Q30010085-9D02A3A9-C621-47EA-ABAC-F859953EA816Q30415176-1851FF19-B4DD-4463-8F86-49465B210A96Q33517082-9C7AB909-8193-422C-B195-4242A4613714Q33552872-F1E552D8-57C5-4D44-A478-637509FEA88CQ34203170-BA98ADB4-12BC-4AF8-9351-FD6A554619D8Q34403732-3B2105AF-B4BC-4820-AF0F-A2EE9BD21A47Q34518000-5C8109B2-BDA0-4E11-9D87-26BEC46CEE75Q34984237-9A13F491-E96F-41D5-9D4B-8B060F18F8FAQ35024084-EBF7241A-78DF-4BAF-8E22-2479757BEF69Q35601697-ABA49360-F7BB-44E5-B1DD-DF828B3A0A33Q35857424-50CD134D-420F-46AD-B8D6-C7E033840252Q35916730-B3CD3FBB-799F-4B2C-8036-4FD66106436CQ36015423-E255CEB5-8D87-4763-8CA0-278FD4BD9D31Q36112824-CF4FF67E-6FE3-424A-BB16-FE62BC029C42Q36143620-79C616CF-4495-43C5-A73F-DC72E49361F3Q36226151-21C34E27-BA18-4A03-9FC5-5FC4DFE96617Q36281754-692AE1D3-8C73-4AF6-8B5D-141AB7A99040Q36367791-7128557F-FF94-434D-95A4-73485991AE33Q36424087-D293D5A5-A857-4B47-9A8B-521E20B0870EQ36898851-5B794F43-544C-485A-A15F-28A5440A6D82Q36926697-18EC49FF-B0B5-42F5-98F5-D761BFF38BA8Q37110624-8335C6B5-1297-4B0E-B13C-6939189EC4B4Q37183096-52375561-B7F7-4518-8B68-F66C40A6F977Q37183848-122E710B-3D9C-4218-A61F-7B4D7A7B96B3Q37532593-1F54C1FF-6C83-4379-BA19-83B0BDFC3F2CQ37959034-5E8306DD-0E14-48F3-AF2F-D56A53C73B17Q38293944-2006F580-113E-49DB-929B-286E98A43D75Q38356666-25B7B7D9-812A-4693-B408-0A1BA2AD00B9Q38644772-AA47AEDC-CBAA-4A10-AAB4-589D62F6ABDFQ39402500-125B7FD9-9AC0-49B4-BB21-0D9A93BEE31FQ39577894-AEB74B77-44E3-4B36-AAB7-4EBE972A8683Q39658813-DBC30BEB-D05C-4F0C-88F0-A8654C853489Q39741159-D7D94E2C-F61C-4264-86F5-8F81D02B6B7AQ40078268-F7D04EDF-7BE9-41CC-8B95-4BE8343B2A22
P2860
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@ast
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@en
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@nl
type
label
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@ast
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@en
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@nl
prefLabel
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@ast
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@en
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@nl
P2093
P2860
P1433
P1476
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
@en
P2093
Eduardo O'Neill
J Victor Garcia
John F Krisko
John L Foster
Lillian S Kuo
P2860
P304
P356
10.1128/JVI.80.3.1311-1320.2006
P407
P577
2006-02-01T00:00:00Z